Phadiatop Allergy is a blood-based screening test used to detect specific IgE antibodies associated with common inhaled allergens, such as pollens, dust mites, moulds, and animal dander. It helps determine whether symptoms may be related to an underlying respiratory allergy or allergic sensitisation. The test is useful for evaluating conditions such as allergic rhinitis, asthma, and recurrent respiratory symptoms and can help guide further allergy testing.
It is designed as a screening panel for common inhalant allergens. The exact allergen composition can vary depending on the laboratory and assay used.
A positive result indicates sensitisation to one or more allergens included in the screening panel. Further specific IgE testing may be needed to identify the particular allergen.
Not by itself. A positive result indicates sensitisation, which must be interpreted alongside symptoms, exposure history, and clinical evaluation.
A negative result suggests that significant sensitisation to the allergens included in the screening panel was not detected. It does not exclude every possible allergy.
It can help determine whether there is evidence of IgE sensitisation to common inhalant allergens in someone with respiratory symptoms, including asthma. It does not diagnose asthma itself.